Get the Stockscreener App
0.00
100.00%
-1.16
Hookipa Pharma Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
HOOKIPA PHARMA INC
See More
Previous Close:
$1.16
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$N/A
Revenue:
$14.86M
Net Income/Loss:
$-56.00M
P/E Ratio:
0.00
EPS:
-4.5442
Net Cash Flow:
$-45.58M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$1.18
Hookipa Pharma Inc Stock (HOOK) Company Profile
Compare HOOK vs VRTX, REGN, ARGX, MRNA, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HOOK
Hookipa Pharma Inc
|
0.00 | 0 | 14.86M | -56.00M | -45.58M | -4.5442 |
VRTX
Vertex Pharmaceuticals Inc
|
514.56 | 130.42B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
793.26 | 81.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
984.04 | 61.56B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
136.62 | 54.54B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
203.35 | 43.59B | 742.00K | -1.37B | -1.07B | -7.0731 |
Hookipa Pharma Inc Stock (HOOK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-20-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-15-24 | Reiterated | RBC Capital Mkts | Outperform |
| Dec-02-22 | Downgrade | BofA Securities | Buy → Underperform |
| Nov-12-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-08-21 | Initiated | Morgan Stanley | Overweight |
| Nov-03-20 | Initiated | Truist | Buy |
| Oct-26-20 | Initiated | JMP Securities | Mkt Outperform |
| Oct-19-20 | Resumed | H.C. Wainwright | Buy |
| Sep-27-19 | Initiated | H.C. Wainwright | Buy |
| May-13-19 | Initiated | BofA/Merrill | Buy |
| May-13-19 | Initiated | RBC Capital Mkts | Outperform |
View All
Hookipa Pharma Inc Stock (HOOK) Latest News
HOOK stock trades quietly as HOOKIPA Pharma focuses on vaccine pipeline - ad-hoc-news.de
HOOKIPA Pharma Number of Employees 2026 | Employee Count & Headcount Data - reveliolabs.com
HOOKIPA Pharma Inc Market Sentiment - Benzinga España
HOOKIPA Pharma (HOOK) AGM 2024 Summary - Quartr
Hookipa Pharma Inc (HOOK) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Hookipa Pharma focuses on clinical-stage immunotherapies as investor interest in biotech stays eleva - Ad-hoc-news.de
HOOKIPA Pharma Inc (HOOK) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
HOOKIPA Pharma Inc (HOOK) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
HOOKIPA Pharma Inc (HOOK) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
HOOKIPA Pharma Inc (HOOK) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
HOOKIPA Pharma Inc (HOOK) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
HOOKIPA Pharma Inc (HOOK) Institutional Confidence - TradingKey
HOOKIPA Pharma Inc (HOOK) Valuation: PE, PB & Fair Value Analysis - TradingKey
HOOKIPA Pharma Inc (HOOK) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
HOOKIPA Pharma Inc (HOOK) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
HOOKIPA Pharma Inc stock (US43906K1007): Immuno-oncology small cap after recent funding and pipeline - AD HOC NEWS
Stock Quote - StocksToTrade
HOOKIPA Pharma stock (US43906K1007): cash runway update and pipeline focus after latest quarterly re - AD HOC NEWS
HOOKIPA Pharma stock (US43906K1007): pipeline update keeps immunotherapy story in focus - AD HOC NEWS
HOOKIPA Pharma Inc.Common Stock (Nasdaq:HOOK) Stock Quote - The Chronicle-Journal
HOOKIPA Pharma Inc stock (US43906K1007): Delisted to OTC amid price volatility - AD HOC NEWS
TradingKey - TradingKey
HOOKIPA Pharma Inc stock (US43906K1007): Biotech focuses on infectious disease and oncology pipeline - AD HOC NEWS
HOOKIPA Pharma Inc stock (US43906K1007): Is its viral vector platform strong enough to unlock biotec - AD HOC NEWS
Can HOOKIPA Pharma Inc reach all time highs this yearQuarterly Portfolio Review & Safe Swing Trade Setup Alerts - baoquankhu1.vn
Earnings Report: Can HOOKIPA Pharma Inc reach all time highs this year - baoquankhu1.vn
New Highs: How does HOOKIPA Pharma Inc compare to its peersQuarterly Risk Review & Community Trade Idea Sharing Platform - baoquankhu1.vn
Winners Losers: Is HOOKIPA Pharma Inc stock a smart retirement pick2026 Support & Resistance & Safe Capital Allocation Plans - baoquankhu1.vn
HOOKIPA Pharma Inc Stock: Areola Virus Vaccine Innovator Seeks Prophylactic Breakthrough with ISIN U - AD HOC NEWS
HOOKIPA Pharma Announces Completion of Sale of Oncology Assets to NeoTrail Therapeutics - markets.businessinsider.com
NeoTrail Therapeutics, Inc. completed the acquisition of Oncology Assets from HOOKIPA Pharma Inc. (OTCPK : HOOK). - MarketScreener
Breakout Move: How does HOOKIPA Pharma Inc compare to its peers2026 Sector Review & Real-Time Volume Triggers - baoquankhu1.vn
New Highs: Will HOOKIPA Pharma Inc benefit from government policy2026 Historical Comparison & High Return Stock Watch Alerts - baoquankhu1.vn
HOOKIPA Pharma Inc stock faces renewed scrutiny after failed merger and pipeline updates in biotech - AD HOC NEWS
Aug Rallies: Can HOOKIPA Pharma Inc reach all time highs this yearStop Loss & Reliable Trade Execution Plans - baoquankhu1.vn
Gilead (GILD) to Acquire HOOK for $10 million - msn.com
HOOKIPA Pharma Stock: What Latest Pipeline Moves Mean for U.S. Investors - AD HOC NEWS
HOOKIPA Pharma T0 Sell Oncology Assets HB-200 And HB-700 To NeoTrail Therapeutics - Nasdaq
HOOKIPA Pharma Inc. Sells Immuno-Oncology Assets HB-200 and HB-700 to NeoTrail Therapeutics - Quiver Quantitative
HOOKIPA Pharma Announces Completion of Sale of HBV and HIV Assets to Gilead - GlobeNewswire
HOOKIPA Pharma to delist from Nasdaq and liquidate following Gilead asset sale - MSN
HOOK Stock Price and Chart — OTC:HOOK - TradingView
HOOK Stock Price, Quote & Chart | HOOKIPA PHARMA INC (NASDAQ:HOOK) - ChartMill
[S-8 POS] HOOKIPA Pharma Inc. SEC Filing - Stock Titan
Hookipa, having sold off vaccines to Gilead, opts to wind down - Fierce Biotech
Hookipa Pharma to Delist from Nasdaq Amid Asset Sale - The Globe and Mail
HOOKIPA Pharma Announces Intention to Voluntarily Delist and Deregister its Common Stock - Yahoo Finance
HOOKIPA Pharma(Delisted) (HOOK) Revenue BreakdownMain Composition - Moomoo
Gilead pays partner Hookipa $10M to take over HBV, HIV therapeutic vaccine programs - Fierce Biotech
HOOK Stock Price, News & Analysis - Stock Titan
Hookipa Pharma stock plunges to 52-week low of $1.11 amid steep decline - Investing.com India
Hookipa Pharma Inc Stock (HOOK) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.04%
Cap:
|
Volume (24h):